Product/Composition:- | Amoxicillin Powder for Suspension |
---|---|
Strength:- | 125 mg/5 mL, 250 mg/5 mL, 400 mg/5 mL |
Form:- | Powder for Suspension |
Reference Brands:- | US: Amoxil, Trimox, Moxatag (extended-release) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Amoxicillin powder for suspension inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to cell lysis and death. It effectively treats respiratory, ear, skin, and urinary infections in children and adults. Benefits include high efficacy, safety, ease of administration, and rapid relief when used appropriately under medical guidance.
Amoxicillin powder for suspension is approved in the EU and US for pediatric and adult bacterial infections. In the EU, brands like Clamoxyl are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers for approval and ongoing pharmacovigilance. For expert assistance with regulatory dossier preparation, compliance, and registration, visit PharmaTradz. We support seamless market access for amoxicillin powder for suspension, ensuring adherence to European and American standards for safe, effective treatment of bacterial infections.